Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $87.2M | $126M | $176M |
| Revenue growth | — | 44.3% | 39.9% |
| Gross profit | $58.1M | $94.4M | $135M |
| Gross margin | 66.6% | 75.1% | 76.8% |
| Operating income | -$72.9M | -$61.2M | -$64.1M |
| Operating margin | -83.6% | -48.7% | -36.4% |
| Net income | -$95.7M | -$96.4M | -$117M |
| Net margin | -109.7% | -76.6% | -66.3% |
| EPS (diluted) | -$25.32 | -$17.98 | -$3.17 |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$76.4M | -$69.0M | -$54.0M |
| Capital expenditures | $6.11M | $4.36M | $5.03M |
| Free cash flow | -$82.5M | -$73.4M | -$59.0M |
| Share buybacks | $228K | — | — |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $123M | $51.4M | $44.8M |
| Total assets | — | $119M | $359M |
| Total liabilities | — | $210M | $58.8M |
| Shareholders' equity | -$778M | -$859M | $301M |
| Retained earnings | -$1.10M | -$971M | -$1.09B |
| Shares (wtd avg diluted) | 4.89M | 5.36M | 36.9M |
Every figure is extracted from Heartflow, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.